(Q22305946)

PubMed

7 February 2023

Giovanni A Fava

1

Giovanni A

Fava

1 reference

PubMed

17144786

7 February 2023

Seung K Park

series ordinal

2

author given names

Seung K

author last names

Park

1 reference

PubMed

17144786

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

7 February 2023

language of work or name

English

0 references

publication date

November 2006

0 references

published in

0 references

volume

6

0 references

issue

11

0 references

page(s)

1735-1740

0 references

cites work

The clinical course of unipolar major depressive disorders

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Residual symptoms in depression: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Social functioning: should it become an endpoint in trials of antidepressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Publication bias in meta-analysis: its causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Assay sensitivity, failed clinical trials, and the conduct of science

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Discontinuing antidepressant treatment in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Tolerance in antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Should depression be managed as a chronic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Prevalence of type 2 diabetes in children in Birmingham

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Treatment approaches to major depressive disorder relapse. Part 1: dose increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Two roads to rapid eye movement latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Six-year outcome of cognitive behavior therapy for prevention of recurrent depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Nutrition and depression: implications for improving mental health among childbearing-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Do essential fatty acids have a role in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

The case for psychological treatment centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

Long-term outcome of lithium prophylaxis in patients initially classified as complete responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Computer assisted learning aids management of course information

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Patients with depression can be taught how to improve recovery

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Integrating mindfulness meditation with cognitive and behavioural therapies: the challenge of combining acceptance- and change-based strategies

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Can long-term treatment with antidepressant drugs worsen the course of depression?

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Tachyphylaxis in Unipolar Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Sequential treatment of mood and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

Reclaiming the lost meanings of medicine

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1735

7 January 2021

10.1586/14737175.6.11.1735

Identifiers

DOI

0 references